Cytek Biosciences IncNASDAQ:CTKB
- LAST PRICE6.5350
- TODAY'S CHANGE (%)0.0350 (0.5385%)
- Bid / Lots6.2700/ 1
- Ask / Lots6.7800/ 1
- Open / Previous Close6.5400 / 6.5000
- Day Range
- 52 Week Range
- Volume519,326
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTKB |
|---|---|---|
| 09:32 ET | 2139 | 6.54 |
| 09:33 ET | 1180 | 6.61 |
| 09:35 ET | 850 | 6.49 |
| 09:37 ET | 700 | 6.48 |
| 09:42 ET | 627 | 6.49 |
| 09:44 ET | 2094 | 6.49 |
| 09:46 ET | 2236 | 6.46 |
| 09:48 ET | 200 | 6.47 |
| 09:50 ET | 2613 | 6.46 |
| 09:51 ET | 514 | 6.48 |
| 09:53 ET | 100 | 6.49 |
| 09:57 ET | 100 | 6.49 |
| 10:00 ET | 476 | 6.48 |
| 10:06 ET | 2511 | 6.485 |
| 10:08 ET | 700 | 6.49 |
| 10:09 ET | 656 | 6.48 |
| 10:11 ET | 199 | 6.48 |
| 10:13 ET | 300 | 6.49 |
| 10:15 ET | 400 | 6.49 |
| 10:18 ET | 100 | 6.48 |
| 10:20 ET | 900 | 6.47 |
| 10:22 ET | 200 | 6.49 |
| 10:24 ET | 561 | 6.48 |
| 10:27 ET | 400 | 6.48 |
| 10:31 ET | 100 | 6.48 |
| 10:33 ET | 1005 | 6.48 |
| 10:36 ET | 100 | 6.48 |
| 10:38 ET | 200 | 6.48 |
| 10:40 ET | 100 | 6.48 |
| 10:42 ET | 1100 | 6.49 |
| 10:44 ET | 911 | 6.485 |
| 10:45 ET | 1294 | 6.49 |
| 10:47 ET | 274 | 6.49 |
| 10:49 ET | 1220 | 6.49 |
| 10:54 ET | 300 | 6.48 |
| 11:00 ET | 227 | 6.485 |
| 11:03 ET | 6948 | 6.46 |
| 11:05 ET | 930 | 6.49 |
| 11:07 ET | 812 | 6.48 |
| 11:09 ET | 300 | 6.49 |
| 11:12 ET | 100 | 6.485 |
| 11:14 ET | 703 | 6.48 |
| 11:16 ET | 200 | 6.485 |
| 11:18 ET | 400 | 6.48 |
| 11:20 ET | 258 | 6.486 |
| 11:21 ET | 1370 | 6.48 |
| 11:23 ET | 627 | 6.49 |
| 11:25 ET | 100 | 6.495 |
| 11:32 ET | 600 | 6.49 |
| 11:36 ET | 200 | 6.495 |
| 11:38 ET | 405 | 6.49 |
| 11:39 ET | 100 | 6.495 |
| 11:41 ET | 3422 | 6.49 |
| 11:43 ET | 1100 | 6.485 |
| 11:45 ET | 200 | 6.48 |
| 11:48 ET | 300 | 6.48 |
| 11:52 ET | 600 | 6.48 |
| 11:54 ET | 1412 | 6.49 |
| 11:56 ET | 1212 | 6.49 |
| 11:57 ET | 300 | 6.4811 |
| 11:59 ET | 300 | 6.49 |
| 12:01 ET | 718 | 6.475 |
| 12:03 ET | 1203 | 6.48 |
| 12:06 ET | 100 | 6.48 |
| 12:08 ET | 200 | 6.48 |
| 12:12 ET | 2195 | 6.48 |
| 12:14 ET | 730 | 6.486 |
| 12:15 ET | 200 | 6.485 |
| 12:17 ET | 600 | 6.48 |
| 12:19 ET | 9379 | 6.48 |
| 12:21 ET | 1353 | 6.485 |
| 12:24 ET | 83476 | 6.5 |
| 12:26 ET | 6545 | 6.525 |
| 12:28 ET | 14194 | 6.53 |
| 12:30 ET | 6078 | 6.51 |
| 12:32 ET | 7875 | 6.52 |
| 12:35 ET | 200 | 6.515 |
| 12:37 ET | 3483 | 6.5 |
| 12:39 ET | 10003 | 6.515 |
| 12:42 ET | 3431 | 6.525 |
| 12:44 ET | 24778 | 6.54 |
| 12:46 ET | 3717 | 6.545 |
| 12:48 ET | 3549 | 6.55 |
| 12:50 ET | 3425 | 6.55 |
| 12:51 ET | 6155 | 6.525 |
| 12:53 ET | 4985 | 6.53 |
| 12:55 ET | 6218 | 6.515 |
| 12:57 ET | 11651 | 6.52 |
| 01:00 ET | 138222 | 6.535 |
Nov 20, 2024
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference, from 4:06PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:06PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 19, 2024
Cytek(R) Biosciences Named "Overall BioTech Company of the Year" in 2024 BioTech Breakthrough Awards Program, from 5:00PM ET on Tuesday Nov 19, 2024 by Dow Jones
5:00PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 11, 2024
DJ Cytek Biosciences Is Maintained at Overweight by Piper Sandler, from 8:01AM ET on Monday Nov 11, 2024 by Dow Jones
8:01AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Cytek(R) Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter, from 5:00PM ET on Thursday Nov 07, 2024 by Dow Jones
5:00PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Cytek Biosciences Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cytek Biosciences Inc | 825.7M | -83.6x | --- |
Pacific Biosciences of California Inc | 484.7M | -1.3x | --- |
AxoGen Inc | 619.2M | -42.1x | --- |
Zynex Inc | 265.3M | 56.2x | +1.09% |
Standard BioTools Inc | 636.6M | -2.6x | --- |
Quanterix Corp | 478.6M | -11.8x | --- |
Company Information
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
Contact Information
- Headquarters
- 47215 LAKEVIEW BOULEVARDFREMONT, CA, United States 94538
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Wenbin Jiang
- Co-Founder, Chief Technology Officer, Director
- Ming Yan
- Chief Financial Officer
- William Mccombe
- Senior Vice President, Global Sales and Services
- Philippe Busque
- Senior Vice President - Business & Corporate Development
- Allen Poirson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $825.7M |
|---|---|
Revenue (TTM) | $201.2M |
Shares Outstanding | 128.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-0.08 |
Book Value | $3.01 |
P/E Ratio | -83.6x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -11.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
